Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
Thorough preclinical evaluation reveals a negligible role of lipocalin 13 in systemic glucose and lipid metabolism. Members of the lipocalin protein family serve as biomarkers for kidney disease and acute phase inflammatory reactions, and are under preclinical development for the diagnosis and thera...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Life Science Alliance LLC
2021-04-01
|
| シリーズ: | Life Science Alliance |
| オンライン･アクセス: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.202000898 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|